Playback speed
10 seconds
Communicating the Risk of Recurrence for Patients With HR+, HER2- Early Breast Cancer
By
Lilly Medical Affairs
FEATURING
Joyce O’Shaughnessy
By
Lilly Medical Affairs
FEATURING
Joyce O’Shaughnessy
0 views
July 26, 2024
In this video, renowned oncologist Dr. Joyce O’Shaugnessy offers valuable insights into best practices for caring for and effectively communicating with patients diagnosed with high-risk HR+, HER2- early breast cancer.
To access additional videos and download free resources click here.
VV-OTHR-US-DEL-3291 © 2024 Lilly USA, LLC. All Rights Reserved.
Comments are disabled for this content.